Follow
Amany Belal
Amany Belal
Professor of Pharmaceutical Chemistry, Faculty of pharmacy, Taif University
Verified email at tu.edu.sa
Title
Cited by
Cited by
Year
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
HA Mahdy, MK Ibrahim, AM Metwaly, A Belal, ABM Mehany, ...
Bioorganic Chemistry 94, 103422, 2020
1262020
Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR WT and EGFR T790M
AA Nasser, IH Eissa, MR Oun, MA El-Zahabi, MS Taghour, A Belal, ...
Organic & biomolecular chemistry 18 (38), 7608-7634, 2020
1032020
Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors
MK Ibrahim, MS Taghour, AM Metwaly, A Belal, ABM Mehany, ...
European journal of medicinal chemistry 155, 117-134, 2018
1012018
Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers
AMS El-Sharief, YA Ammar, A Belal, MAMS El-Sharief, YA Mohamed, ...
Bioorganic chemistry 85, 399-412, 2019
872019
Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity
YA Ammar, AMS El-Sharief, A Belal, SY Abbas, YA Mohamed, ...
European journal of medicinal chemistry 156, 918-932, 2018
822018
Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma
IH Eissa, MK Ibrahim, AM Metwaly, A Belal, ABM Mehany, AA Abdelhady, ...
Bioorganic Chemistry 107, 104532, 2021
692021
Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5 (4 H)-ones as potential tubulin polymerization inhibitors targeting the colchicine …
AM El-Naggar, IH Eissa, A Belal, AA El-Sayed
RSC advances 10 (5), 2791-2811, 2020
612020
Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors
IH Eissa, AM Metwaly, A Belal, ABM Mehany, RR Ayyad, K El‐Adl, ...
Archiv der Pharmazie 352 (11), 1900123, 2019
612019
Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II …
AGA El-Helby, H Sakr, RR Ayyad, HA Mahdy, MM Khalifa, A Belal, ...
Bioorganic chemistry 103, 104233, 2020
572020
Pyrrolizines: Promising scaffolds for anticancer drugs
A Belal, BEDM El-Gendy
Bioorganic & Medicinal Chemistry 22 (1), 46-53, 2014
572014
Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR …
C Ma, MS Taghour, A Belal, ABM Mehany, N Mostafa, A Nabeeh, IH Eissa, ...
Frontiers in chemistry 9, 725135, 2021
562021
New benzothiazole/benzoxazole-pyrazole hybrids with potential as COX inhibitors: design, synthesis and anticancer activity evaluation
A Belal, MA Abdelgawad
Research on Chemical Intermediates 43, 3859-3872, 2017
492017
Synthesis, Anti‐B reast Cancer Activity, and Molecular Modeling of Some Benzothiazole and Benzoxazole Derivatives
MA Abdelgawad, A Belal, HA Omar, L Hegazy, ME Rateb
Archiv der Pharmazie 346 (7), 534-541, 2013
472013
Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors
EA Fayed, YA Ammar, MA Saleh, AH Bayoumi, A Belal, ABM Mehany, ...
Journal of Molecular Structure 1236, 130317, 2021
442021
Design, synthesis, antimicrobial activity and molecular docking studies of some novel di-substituted sulfonylquinoxaline derivatives
YA Ammar, AA Farag, AM Ali, A Ragab, AA Askar, DM Elsisi, A Belal
Bioorganic Chemistry 104, 104164, 2020
422020
Development of adamantane scaffold containing 1, 3, 4-thiadiazole derivatives: Design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR
MMS Wassel, YA Ammar, GAME Ali, A Belal, ABM Mehany, A Ragab
Bioorganic Chemistry 110, 104794, 2021
412021
Design, synthesis, molecular docking and antiproliferative activity of some novel benzothiazole derivatives targeting EGFR/HER2 and TS
KRA Abdellatif, A Belal, MT El-Saadi, NH Amin, EG Said, LR Hemeda
Bioorganic Chemistry 101, 103976, 2020
362020
Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 …
A Belal, NM Abdel Gawad, ABM Mehany, MAS Abourehab, H Elkady, ...
Journal of enzyme inhibition and medicinal chemistry 37 (1), 1884-1902, 2022
352022
Hybridized quinoline derivatives as anticancer agents: design, synthesis, biological evaluation and molecular docking
MR Selim, MA Zahran, A Belal, MS Abusaif, SA Shedid, A Mehany, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019
342019
Multi-phase in silico discovery of potential SARS-CoV-2 RNA-dependent RNA polymerase inhibitors among 3009 clinical and FDA-approved related drugs
EB Elkaeed, H Elkady, A Belal, BA Alsfouk, TH Ibrahim, M Abdelmoaty, ...
Processes 10 (3), 530, 2022
332022
The system can't perform the operation now. Try again later.
Articles 1–20